A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
Top Cited Papers
- 11 April 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 27 (22) , 2667-2674
- https://doi.org/10.1093/eurheartj/ehl334
Abstract
Aims The role of aspirin in patients with coronary artery disease (CAD) is well established, yet patients happen to discontinue aspirin according to physician’s advice or unsupervised. We thus undertook a systematic review to appraise the hazards inherent to aspirin withdrawal or non-compliance in subjects at risk for or with CAD.Keywords
This publication has 13 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2006 UpdateCirculation, 2006
- Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery DiseaseCirculation, 2006
- Long-term adherence with cardiovascular drug regimensAmerican Heart Journal, 2005
- Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation†European Heart Journal, 2005
- Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25 307 patientsEuropean Heart Journal, 2005
- Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting StentsJournal of the American College of Cardiology, 2005
- Coronary syndromes following aspirin withdrawalJournal of the American College of Cardiology, 2005
- Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary SyndromesCirculation, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Aspirin Protects Endothelial Cells From Oxidant Damage Via the Nitric Oxide-cGMP PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2003